NRAS and melanoma: To confirm the effectiveness of the MALAT1-targeting ASO in MALAT1-inhibition, we exposed NRAS-mutant D04 melanoma cells to non-targeting Control-ASO or MALAT1-ASO at a concentration of 50 nM for one day.